AKTX – akari therapeutics plc - american depositary shares (US:NASDAQ)
Stock Stats
News
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Akari Therapeutics, Plc (NASDAQ: AKTX) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics [Yahoo! Finance]
Akari Therapeutics and Peak Bio Announce Portfolio Prioritization Plan for Combined Go-Forward Merger Entity [Yahoo! Finance]
Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics
Form 4 Akari Therapeutics Plc For: May 01 Filed by: DICICCO WENDY F
Form 425 Akari Therapeutics Plc Filed by: Akari Therapeutics Plc
Form 8-K Akari Therapeutics Plc For: Apr 25
Form 4 Akari Therapeutics Plc For: Apr 26 Filed by: Jacques Rachelle Suzanne
Form 8-K Akari Therapeutics Plc For: Apr 05
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.